But FDA was correct
In the headline of an Oct. 29 story about the FDA’s approval of a new leukemia drug, The Associated Press misspelled the name of the company and the disease. The drug company is Novartis, not Norvatis. The disease is leukemia, not leukemis. Link
Report an error